Trump's cuts will end lifesaving medical research – and people will die | Opinion
National Institutes of Health grants are essential for lifesaving medical research. A Trump administration policy now ...
Ars Technica8d
Scientific breakthroughs are hard without money for research infrastructure
Biomedical research in the US is world class in part because of a longstanding partnership between universities and the federal government. On Feb. 7, 2025, the US National Institutes of Health ...
HUB7d
NIH funds research that leads directly to cancer treatments, clinical trials
Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...
ophthalmologytimes9d
Clearside Biomedical presents new data from CLS-AX ODYSSEY phase 2b trial
The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...
Nasdaq10d
Clearside Biomedical Presents Subgroup Analyses from ODYSSEY Phase 2b Clinical Trial for CLS-AX at Angiogenesis 2025 Meeting
Clearside Biomedical, Inc. has announced the presentation of two subgroup analyses from its ODYSSEY Phase 2b clinical trial ... advancement in the company's research portfolio.